Call or text us at 772-320-9791 were happy to help before you move forward
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Tirzepatide (Mounjaro for T2D, Zepbound for obesity) is Eli Lilly's FDA-approved dual GLP-1/GIP receptor agonist and the first approved twincretin therapy
Which enzymes catalyze glutathione conjugation
After May 22, 2025, 503B facilities will also cease, further limiting options unless the court intervenes
For the most accurate dosing guidelines, please reach out to a healthcare professional
Decreases Stress Hormones Lack of sleep increases cortisol, a stress hormone that can worsen acne and dullness